LCMS webinars focusing on LC/TOF - page 22

Development of RapidFire Native Mass Spectrometry and Collision Induced Unfolding Methodologies for High Throughput Screening.

We will look at the differences between untargeted and targeted MS imaging.

Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

Presentations will cover areas ranging from uncovering the molecular mechanisms of disease pathology, to the latest technological developments in diagnostics and treatment.

The Hidden Pathophysiology of Lipids and Proteins in Alzheimer’s Revealed with Ion Mobility MS and Quantitative QQQ Biomarker Assays.

We will examine the types of MS imaging techniques on the market and the platforms on which they can be run.

Emerging therapies like Synthetic Peptides & Oligonucleotides are catching the attention due to its capabilities to improve their properties.

The Laser-ablation ICP-MS, which acquires information on the element distribution, and the award-winning iMScope QT MALDI-MS Microscope, which provide information on the compound distribution.

In our applications demo lab we will show the simplicity of changing between MALDI and DESI XS modes, both available on the MRT instrument.

Towards more Comprehensive Characterization of PFAS Exposure using Ion Mobility and High-Resolution Mass Spectrometry.